Literature DB >> 22702335

Etiologies of Parkinsonism in a century-long autopsy-based cohort.

Judit Horvath1, Pierre R Burkhard, Constantin Bouras, Enikö Kövari.   

Abstract

We investigated the distribution of different etiologies underlying Parkinsonism in a hospital-based autopsy collection, studied the demographic data and evaluated diagnostic accuracy using histopathological examination as the gold standard. Out of a total of 9359 consecutive autopsy cases collected between 1914 and 2010, we identified 261 individuals who carried a clinical diagnosis of a Parkinsonian syndrome at death. A detailed neuropathological examination revealed idiopathic Parkinson's disease (PD) in 62.2%, progressive supranuclear palsy (PSP) in 4.2%, multiple system atrophy (MSA) in 2.3%, corticobasal degeneration (CBD) in 1.2%, postencephalitic Parkinsonism (PEP) in 2.7%, vascular Parkinsonism (VaP) in 8.8% and Alzheimer-type pathology (ATP) of the substantia nigra in 8%. The diagnostic accuracy of PD in our cohort was lower (71.2%) than those reported in previous studies, although it tended to increase during the last decades up to 85.7%. Of particular interest, we found that PD, while being the most frequent cause of Parkinsonism, was greatly overdiagnosed, with VaP and ATP being the most frequent confounding conditions.
© 2012 The Authors; Brain Pathology © 2012 International Society of Neuropathology.

Entities:  

Mesh:

Year:  2012        PMID: 22702335     DOI: 10.1111/j.1750-3639.2012.00611.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  14 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

2.  Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.

Authors:  Joshua M Shulman; Lei Yu; Aron S Buchman; Denis A Evans; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

3.  Reversible parkinsonism due to a large intracranial tumour.

Authors:  Helena Rocha; António Cerejo; Maria Carolina Garrett; João Massano
Journal:  BMJ Case Rep       Date:  2012-12-23

4.  Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.

Authors:  Helena M van der Holst; Inge W M van Uden; Anil M Tuladhar; Karlijn F de Laat; Anouk G W van Norden; David G Norris; Ewoud J van Dijk; Rianne A J Esselink; Bram Platel; Frank-Erik de Leeuw
Journal:  Neurology       Date:  2015-10-07       Impact factor: 9.910

5.  Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis.

Authors:  Dongjun Dai; Yunliang Wang; Lingyan Wang; Jinfeng Li; Qingqing Ma; Jianmin Tao; Xingyu Zhou; Hanlin Zhou; Yi Jiang; Guanghui Pan; Limin Xu; Ping Ru; Danfeng Lin; Jun Pan; Leiting Xu; Meng Ye; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-01-13

Review 6.  Therapeutic Management of the Overlapping Syndromes of Atypical Parkinsonism.

Authors:  Nikolaos Giagkou; Maria Stamelou
Journal:  CNS Drugs       Date:  2018-09       Impact factor: 6.497

7.  Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

Authors:  Thilo van Eimeren; Angelo Antonini; Daniela Berg; Nico Bohnen; Roberto Ceravolo; Alexander Drzezga; Günter U Höglinger; Makoto Higuchi; Stephane Lehericy; Simon Lewis; Oury Monchi; Peter Nestor; Matej Ondrus; Nicola Pavese; María Cecilia Peralta; Paola Piccini; José Ángel Pineda-Pardo; Irena Rektorová; María Rodríguez-Oroz; Axel Rominger; Klaus Seppi; A Jon Stoessl; Alessandro Tessitore; Stephane Thobois; Valtteri Kaasinen; Gregor Wenning; Hartwig R Siebner; Antonio P Strafella; James B Rowe
Journal:  Alzheimers Dement (Amst)       Date:  2019-04-02

Review 8.  Neuroimaging in Vascular Parkinsonism.

Authors:  Karen K Y Ma; Shi Lin; Vincent C T Mok
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

9.  Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.

Authors:  H Geut; D H Hepp; E Foncke; H W Berendse; J M Rozemuller; I Huitinga; W D J van de Berg
Journal:  Acta Neuropathol Commun       Date:  2020-03-26       Impact factor: 7.801

10.  Identifying incident Parkinson's disease using administrative diagnostic codes: a validation study.

Authors:  Brett J Peterson; Walter A Rocca; James H Bower; Rodolfo Savica; Michelle M Mielke
Journal:  Clin Park Relat Disord       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.